140 related articles for article (PubMed ID: 28233344)
1. Evaluation of a newly developed quantitative determination kit for tumor marker CA15-3 with chemiluminescent assay.
Li P; Ye H; Liu J; Jin H; Lin Y; Yan S; Yu Y; Gao L; Xu F; Zhang Z
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28233344
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a newly developed chemiluminescence immunoassay for detecting cardiac troponin T.
Wang J; Fang Y; Li P; Lin H; Jin H; Gao L; Ge S; Zhang ZY
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28940712
[TBL] [Abstract][Full Text] [Related]
3. Performance evaluation of CA242 by flow fluorescence assay.
Hou Y; Chen Y; Sun J; Geng J; Jin H; Zhang Z
Medicine (Baltimore); 2021 Apr; 100(15):e25301. PubMed ID: 33847629
[TBL] [Abstract][Full Text] [Related]
4. Performance evaluation of a chemiluminescence microparticle immunoassay for CK-MB.
Lin ZY; Fang YZ; Jin HW; Lin HY; Dai Z; Luo Q; Li HW; Lin YL; Huang SZ; Gao L; Xu FH; Zhang ZY
J Clin Lab Anal; 2018 Jul; 32(6):e22426. PubMed ID: 29604095
[TBL] [Abstract][Full Text] [Related]
5. Performance Evaluation of a Newly Developed Chemiluminescent Assay Kit for Detection of Neuron-Specific Eno.
Qing L; Chun-Lei Y; Hui-Ming Y; Hong-Wei J; Zhi-Yuan L; Yan-Ling L; Hong-Wei L; Yang Y; Shui-Di Y; Yong-Zhi L; Jiang-Wu L; Zu-Xing W; Yi-Juan C; Zhong-Ying Z
Clin Lab; 2018 Jul; 64(7):1233-1240. PubMed ID: 30146825
[TBL] [Abstract][Full Text] [Related]
6. Sensitive and Selective Immunofluorescence Assay for CA15-3 Detection Using Fluorescein Derivative A10254.
Huang X; Liu H; Fang W; Lin Y; Tan Y
Protein Pept Lett; 2018; 25(8):776-782. PubMed ID: 30081782
[TBL] [Abstract][Full Text] [Related]
7. Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access BR Monitor assay on the UniCel Dxl 800 Immunoassay System.
Molina R; Gion M; Gressner A; Troalen F; Auge JM; Holdenrieder S; Zancan M; Wycislo M; Stieber P
Clin Chem Lab Med; 2008; 46(5):612-22. PubMed ID: 18598203
[TBL] [Abstract][Full Text] [Related]
8. The Establishment of an HE4-CLIA Method and the Combined Analysis of HE4 and CA125 in Ovarian Cancer.
Zhang Q; Wang CR; Yu JP; Ma Q; Xu WW
J Clin Lab Anal; 2016 Sep; 30(5):709-18. PubMed ID: 26990679
[TBL] [Abstract][Full Text] [Related]
9. Sensitive detection of tumor marker CA15-3 in human serum by capillary electrophoretic immunoassay with chemiluminescence detection.
Liu YM; Zheng YL; Cao JT; Chen YH; Li FR
J Sep Sci; 2008 Apr; 31(6-7):1151-5. PubMed ID: 18335473
[TBL] [Abstract][Full Text] [Related]
10. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
11. Performance Evaluation of an Enzyme-Linked Immunosorbent Assay for Seven Autoantibodies in Lung Cancer.
Yin-Yu M; Fu-Yi X; Fei-Bo W; Ri-Yi Z; Xiao-Lin Y
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969073
[TBL] [Abstract][Full Text] [Related]
12. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and characterization of the monoclonal antibodies against human CA15-3 and establishment of a sandwich CLIA system].
Cao L; Lan X; Wei D; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):66-70. PubMed ID: 24405600
[TBL] [Abstract][Full Text] [Related]
14. A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair.
Mohammadi S; Salimi A; Hamd-Ghadareh S; Fathi F; Soleimani F
Anal Biochem; 2018 Sep; 557():18-26. PubMed ID: 29908158
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer.
Gion M; Mione R; Leon AE; Dittadi R
Clin Chem; 1999 May; 45(5):630-7. PubMed ID: 10222349
[TBL] [Abstract][Full Text] [Related]
16. Serum Carboxypeptidase N1 Serves as a Potential Biomarker Complementing CA15-3 for Breast Cancer.
Cui R; Wang C; Zhao Q; Wang Y; Li Y
Anticancer Agents Med Chem; 2020; 20(17):2053-2065. PubMed ID: 32619179
[TBL] [Abstract][Full Text] [Related]
17. A Novel Carbon Quantum Dots Signal Amplification Strategy Coupled with Sandwich Electrochemiluminescence Immunosensor for the Detection of CA15-3 in Human Serum.
Qin D; Jiang X; Mo G; Feng J; Yu C; Deng B
ACS Sens; 2019 Feb; 4(2):504-512. PubMed ID: 30693767
[TBL] [Abstract][Full Text] [Related]
18. The correlation of CA15.3 and TPS with tumor course in patients with metastatic breast cancer.
Pronk LC; Stoter G; van Putten WL; de Wit R
J Cancer Res Clin Oncol; 1997; 123(2):128-32. PubMed ID: 9030253
[TBL] [Abstract][Full Text] [Related]
19. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II.
Fujita K; Kinukawa H; Ohno K; Ito Y; Saegusa H; Yoshimura T
Clin Biochem; 2015 Dec; 48(18):1330-6. PubMed ID: 26210849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
